Marksans Pharma Q1 profit jumps 43.6%; broader market trends mixed
Marksans Pharma reported a 43.6% year-on-year rise in net profit for Q1FY27, driven by a 74.7% jump in UK and Europe revenues to Rs 356 crore and 15.1% growth in US revenues…
Business & Economy1 month ago
Marksans Pharma reported a 43.6% year-on-year rise in net profit for Q1FY27, driven by a 74.7% jump in UK and Europe revenues to Rs 356 crore and 15.1% growth in US revenues…
All of India’s news in one place, summarised from multiple outlets so you can read more in less time. Every story links back to the original reporting.









